Sai Life Sciences Limited
ListedMainboardPharmaceuticals & Healthcare · NSE / BSE
Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.
Price Band
₹522 – ₹549
Issue Size
₹3043 Cr
Lot Size
27 shares
GMP
₹71
+12.9%
Est. Listing
₹620
at current GMP
Subscribed
10.27x
overall
Open
11 Dec 2024
Close
13 Dec 2024
Allotment
16 Dec 2024
Refund
17 Dec 2024
Demat Credit
18 Dec 2024
Listing
18 Dec 2024
Last updated 12 days ago
Live Grey Market Premium
Sai Life Sciences Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹71+12.9%
Issue Price (Upper)
₹549
Band: ₹522 – ₹549
Estimated Listing Price
₹620
Upper price + GMP
Lot Size
27 shares
Min investment ₹14,823
Estimated Profit / Lot
₹1,917
27 × ₹71
Sai Life Sciences Limited GMP Historical Trend
GMP History
Grey Market Premium trend
+₹71
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹71 | 12.9% | ₹620 |
| 30 Oct 2026 | +₹71 | 12.9% | ₹620 |
| 29 Oct 2026 | +₹64 | 11.6% | ₹613 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Sai Life Sciences Limited Public Issue & Market Profile
Sai Life Sciences Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹3,042.62 Crores. The shares are offered at a price band of ₹522 to ₹549 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2024-12-13, the basis of allotment is scheduled to be finalized on 2024-12-16. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Sai Life Sciences Limited IPO GMP today?
The latest grey market premium for Sai Life Sciences Limited IPO is ₹71, which indicates an expected listing price of ₹620.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.